What changed in Quest Diagnostics Inc's latest annual report
In the year ended 31 Dec 2025, Quest Diagnostics Inc's revenue rose 11.8% to USD 11.04bn, from USD 9.87bn; net income rose 13.9% to USD 992.00m, from USD 871.00m; cash and cash equivalents fell 23.5% to USD 420.00m, from USD 549.00m.
Year ended 31 Dec 2025. Source: 10-K filed 26 Feb 2026, read it on SEC EDGAR.
USD 9.87bn to USD 11.04bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 9.87bn | 11.04bn | Up 11.8% |
| Net income | 871.00m | 992.00m | Up 13.9% |
| Total assets | 16.15bn | 16.23bn | Up 0.4% |
| Long-term debt | 5.62bn | 5.17bn | Down 8% |
| Cash and cash equivalents | 549.00m | 420.00m | Down 23.5% |
| Shareholders' equity | 6.78bn | 7.17bn | Up 5.8% |
Questions people ask
Did Quest Diagnostics Inc's revenue grow last year?
Revenue grew 11.8%, from USD 9.87bn to USD 11.04bn in the year ended 31 Dec 2025.
Is Quest Diagnostics Inc profitable?
Yes. Net income was USD 992.00m in the year ended 31 Dec 2025. The year before: USD 871.00m.
How much cash and debt does Quest Diagnostics Inc have?
At its latest year end (31 Dec 2025), Quest Diagnostics Inc reported cash and cash equivalents of USD 420.00m and long-term debt of USD 5.17bn.
Where do these numbers come from?
From Quest Diagnostics Inc's own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Quest Diagnostics Inc?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Services-Medical Laboratories companies
- Natera, Inc.Total liabilities up 47.4%
- Labcorp Holdings Inc.Cash and cash equivalents down 65%
- Guardant Health, Inc.Total assets up 35.5%